Home/Applied Tissue Technologies/Elof Eriksson, MD, PhD

EE

Elof Eriksson, MD, PhD

Chief Medical Officer, Founder

Applied Tissue Technologies

Therapeutic Areas

Wound Healing Burns Traumatic Injuries

Applied Tissue Technologies Pipeline

Drug	Indication	Phase
PWD for NPWT (Phase II Enhancement)	Incisional Wounds	Phase 2
PWD for Ocular & Periocular Injuries	Ocular Injuries, Infections, and Periocular Burns	Clinical Trial

Leadership Team at Applied Tissue Technologies

Michael Broomhead, MBA

Chief Executive Officer

Kristo Nuutila, MSc, PhD

Director of Research

View full Applied Tissue Technologies profile